Vanguard Group Inc Cortexyme, Inc. Transaction History
Vanguard Group Inc
- $5.57 Trillion
- Q4 2024
A detailed history of Vanguard Group Inc transactions in Cortexyme, Inc. stock. As of the latest transaction made, Vanguard Group Inc holds 1,272,340 shares of CRTX stock, worth $1.64 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
1,272,340
Previous 1,199,648
6.06%
Holding current value
$1.64 Million
Previous $1.55 Million
6.08%
% of portfolio
0.0%
Previous 0.0%
Shares
14 transactions
Others Institutions Holding CRTX
# of Institutions
42Shares Held
5.41MCall Options Held
90.8KPut Options Held
0-
Epiq Capital Group, LLC San Francisco, CA825KShares$1.06 Million0.31% of portfolio
-
Jim Simons Renaissance Technologies LLC | New York, Ny523KShares$674,1230.0% of portfolio
-
Almitas Capital LLC Santa Monica, CA383KShares$493,9170.23% of portfolio
-
Geode Capital Management, LLC Boston, MA376KShares$484,9520.0% of portfolio
-
Black Rock Inc. New York, NY355KShares$457,6760.0% of portfolio
About Cortexyme, Inc.
- Ticker CRTX
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 36,150,800
- Market Cap $70.5M